Palliative Homecare in Chronic Liver Disease: A Cohort Analysis of Factors and Outcomes Associated with Home Palliative Care in Patients with End-Stage Liver Disease
Journal of Palliative Care · 2025
DOI: 10.1177/08258597241296116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Palliative Care, 2025. Verfasst von Hugo M Oliveira und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social Sciences and Health, Faculty of Medicine, University of Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Palliative Care, End Stage Liver Disease, Home Care Services. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Palliativpflege
Abstract (Originalsprache)
Objective
The prevalence and mortality of chronic liver disease has risen significantly. In end-stage liver disease (ESLD), the survival of patients is approximately 2 years. Despite the poor prognosis and high symptom burden, integration of palliative care in ESLD is reduced, and the majority of patients continue to die in inpatient care. We aim to assess predictors and outcomes of home palliative care, as well as factors associated with death at home in patients with ESLD.
Methods
Retrospective cohort study of patients with ESLD, followed by a palliative care team between 2017 and 2022. Information regarding patient demographics, ESLD etiology, decompensations, and interventions was collected. Two-sided tests were used to identify factors associated with home palliative care.
Results
We analyzed 75 patients: 44% had home palliative care and 33% died at home. ESLD patients with home palliative care were older (72.52 vs 64.45; p = 0.002), had a longer palliative care intervention time (149.97 ± 196.23 vs 43.69 ± 100.60 days; p = 0.007), higher rates of ascites or hepatic encephalopathy (χ 2 = 11.024; p = 0.029), and hepatocarcinoma (90.9% vs 64.3%; p = 0.007). Patients with home palliative care had a reduction in-hospital admissions (2.61 vs 1.06; p = 0.000) and a greater probability of death at home (66.7% vs 33.3%; p = 0.000). Patients who died at home (33.3%) were older (72.20 vs 64.40; p = 0.000) and had longer palliative care intervention time (178.80 ± 211.78 vs 46.28 ± 99.67 days; p = 0.006).
Conclusion
Home palliative care in ESLD differs based on demographics and disease complications, with a positive impact of homecare translated into a reduction in hospital admissions and an increased probability of death at home.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Social Sciences and Health, Faculty of Medicine, University of Porto, Porto, Portugal.
- Palliative Care Unit, Matosinhos Local Health Unit, Matosinhos, Portugal.
ORCID-Profile: Hugo M Oliveira
Zitieren
APA
Oliveira, H. M., Rocha, C., Rego, M. F., & Nunes, R. (2025). Palliative Homecare in Chronic Liver Disease: A Cohort Analysis of Factors and Outcomes Associated with Home Palliative Care in Patients with End-Stage Liver Disease. Journal of Palliative Care. https://doi.org/10.1177/08258597241296116
Vancouver
Oliveira HM, Rocha C, Rego MF, Nunes R. Palliative Homecare in Chronic Liver Disease: A Cohort Analysis of Factors and Outcomes Associated with Home Palliative Care in Patients with End-Stage Liver Disease. Journal of Palliative Care. 2025. doi:10.1177/08258597241296116
BibTeX
@article{Oliveira2025,
author = {Oliveira, Hugo M and Rocha, Céu and Rego, Maria Francisca and Nunes, Rui},
title = {Palliative Homecare in Chronic Liver Disease: A Cohort Analysis of Factors and Outcomes Associated with Home Palliative Care in Patients with End-Stage Liver Disease},
journal = {Journal of Palliative Care},
year = {2025},
doi = {10.1177/08258597241296116}
}
EUVIMED